Guidance Documents
Seven Elements of an Effective Compliance Program
Evaluation of Corporate Compliance Programs
(Revised March 2023)
Evaluation of Corporate Compliance Programs in Criminal Antitrust Investigations
(July 2019)
Measuring Compliance Program Effectiveness: A Resource Guide
Practical Guidance for Healthcare Governing Boards on Compliance Oversight
Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities - Questions and Answers Guidance for Industry and Review Staff
(June 2018: FINAL)
Medical Product Communications That Are Consistent With the FDA-Required Labeling - Questions and Answers Guidance for Industry
(June 2018: FINAL)
OIG Advisory Opinions (list after Practical Guidance for Healthcare Governing Boards on Compliance Oversight)
(June 2018: FINAL)